Outpatient medical abortion is safe and effective through 70 days gestation

被引:32
|
作者
Abbas, Dina [1 ]
Chong, Erica [1 ]
Raymond, Elizabeth G. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TERMINATION; PREGNANCY; REGIMEN;
D O I
10.1016/j.contraception.2015.06.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Data show that an outpatient regimen of 200-mg mifepristone followed by a single dose of misoprostol is safe and effective for medical abortion for up to 70 days from last menstrual period (LMP). Yet, many clinics only provide services up to 63 days LMP, and some practice guidelines do not recommend the higher gestational age limit. We review the studies published to date that include women 64 to 70 days LMP and conclude that outpatient medical abortion is safe and effective in this interval and that there are no clinically meaningful differences between outcomes at 57 to 63 days LMP and 64 to 70 days LMP. Updating clinical protocols and revising the Food and Drug administration label for Mifeprex (R) to change the indication for termination of pregnancies through 70 days LMP will give women more choices and expand access to safe abortion services. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 50 条
  • [31] Consistency of medical abortion efficacy from 5 through 14 weeks' gestation
    Garbin, Olivier
    Vayssiere, Christophe
    Bettahar-Lebugle, Karima
    Nisand, Israel
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 129 (01): : 36 - 40
  • [32] ACCEPTABILITY OF AN OUTPATIENT REGIMEN OF MEDICAL ABORTION WITH MIFEPRISTONE AND 800 MCG MISOPROSTOL ADMINISTERED BUCCALLY OR SUBLINGUALLY AT 71-84 DAYS OF GESTATION: A SERIES OF EXPLORATORY STUDIES
    Abbas, D.
    Blum, J.
    Ngoc, N.
    Winikoff, B.
    CONTRACEPTION, 2014, 89 (05) : 480 - 480
  • [33] Toward safe and effective medical abortion (vol 281, pg 520, 1998)
    Ewart, WR
    Winikoff, B
    SCIENCE, 1998, 281 (5380) : 1146 - 1146
  • [34] Methotrexate with vaginal misoprostol is a safe, highly effective regimen for early medical abortion
    Hollander, D
    FAMILY PLANNING PERSPECTIVES, 1997, 29 (01): : 45 - 46
  • [35] Efficacy and Safety of a Regimen for Medical Abortion up to 63 Days of Gestation: A Retrospective Study in Northern Greece
    Kelesidou, Vera
    Tsakiridis, Ioannis
    Mitta, Kyriaki
    Virgiliou, Andriana
    Michos, Georgios
    Kougioumtsidou, Anna
    Mamopoulos, Apostolos
    Dagklis, Themistoklis
    Kalogiannidis, Ioannis
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [36] Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost -: A randomized controlled trial
    Dhall, GI
    Calder, A
    Gomez-Alzugaray, M
    Ho, PC
    Pretnar, AD
    Chen, JK
    Bygdeman, M
    Kovacs, L
    Kavkasidze, G
    Song, LJ
    Van Look, PFA
    von Hertzen, H
    Noonan, E
    Ali, M
    Peregoudov, A
    Laperrière, N
    Grimes, D
    Ali, M
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (05) : 447 - 451
  • [37] METHOTREXATE AND MISOPROSTOL FOR ABORTION AT 57-63 DAYS GESTATION
    CREININ, MD
    CONTRACEPTION, 1994, 50 (06) : 511 - 515
  • [38] Early surgical abortion: Safe and effective
    Kara, Fatih
    Dogan, Nasuh Utku
    Bati, Serap
    Demir, Senay
    Durduran, Yasemin
    Celik, Cetin
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02): : 120 - 126
  • [39] Misoprostol Alone Is Safe and Effective for Abortion
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2024, 124 (02) : 56 - 56
  • [40] Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days
    Kallner, H. Kopp
    Fiala, C.
    Stephansson, O.
    Gemzell-Danielsson, K.
    HUMAN REPRODUCTION, 2010, 25 (05) : 1153 - 1157